Cancer

European regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse cardiovascular events

Bagsværd, Denmark, 25 July 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products…

2 years ago

Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market

LONDON, UK / ACCESSWIRE / July 26, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed…

2 years ago

Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland

CHICAGO, IL / ACCESSWIRE / July 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

2 years ago

LA ROCHE-POSAY IS THE OFFICIAL SUNSCREEN PARTNER OF THE MUBADALA CITI DC OPEN

The worldwide expert in UV protection continues its SOS – Save Our Skin campaign to inform the public about the…

2 years ago

CMS Establishes National Payment for AI Breakthrough in Prostate Cancer Diagnosis, Unfold AI

Improved Access to Personalized Prostate Cancer Care with CMS and AMA Support for Unfold AI CULVER CITY, Calif., July 25,…

2 years ago

BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases

Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J., July 25, 2024…

2 years ago

The Caris Precision Oncology Alliance Welcomes The University of Mississippi Medical Center

Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine by…

2 years ago

Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar

CHICAGO, IL / ACCESSWIRE / July 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

2 years ago

CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference

HOUSTON, TX / ACCESSWIRE / July 25, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company…

2 years ago